CB
TEVA icon

Chemical Bank’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Chemical Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-28,490
Closed -$947K – 373
2017
Q2 		$947K Sell
28,490
-1,401
-5% -$43.4K 0.1% 184
2017
Q1 		$959K Sell
29,891
-680
-2% -$23.2K 0.11% 172
2016
Q4 		$1.11M Sell
30,571
-2,008
-6% -$80.2K 0.13% 157
2016
Q3 		$1.5M Buy
32,579
+5,547
+21% +$289K 0.2% 114
2016
Q2 		$1.36M Sell
27,032
-6,705
-20% -$357K 0.19% 118
2016
Q1 		$1.8M Sell
33,737
-2,260
-6% -$133K 0.25% 92
2015
Q4 		$2.36M Sell
35,997
-1,275
-3% -$78.8K 0.33% 82
2015
Q3 		$2.1M Sell
37,272
-8
-0% -$519 0.3% 88
2015
Q2 		$2.2M Buy
37,280
+100
+0.3% +$6.17K 0.29% 85
2015
Q1 		$2.32M Buy
37,180
+50
+0.1% +$2.91K 0.3% 81
2014
Q4 		$2.14M Buy
37,130
+7,800
+27% +$435K 0.28% 88
2014
Q3 		$1.58M Sell
29,330
-245
-0.8% -$13K 0.27% 83
2014
Q2 		$1.55M Buy
29,575
+477
+2% +$24.4K 0.26% 85
2014
Q1 		$1.54M Sell
29,098
-4,209
-13% -$195K 0.28% 85
2013
Q4 		$1.33M Sell
33,307
-4,415
-12% -$174K 0.24% 95
2013
Q3 		$1.43M Sell
37,722
-4,405
-10% -$172K 0.28% 78
2013
Q2 		$1.65M Buy
+42,127
New +$1.64M 0.33% 71

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Chemical Bank's TEVA Position: Q3 2017 in Review

Chemical Bank sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 28,490 shares — an estimated $947K sold.

Chemical Bank first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $2.36M in Q4 2015. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Chemical Bank reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
  • Chemical Bank sold 28,490 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $947K.
  • Chemical Bank first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 17 quarters.
  • Chemical Bank's Teva Pharmaceutical Industries Limited position peaked at $2.36M in Q4 2015.
  • 537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on Chemical Bank's 13F filing for Q3 2017, filed 14 Nov 2017.